Tom Price’s heated hearing is unlikely to derail his nomination

New York Times

24 January 2017 - In a heated confirmation hearing that focused on ethical issues, President Trump’s nominee for secretary of health and human services, Representative Tom Price, defended his trading of medical and pharmaceutical stocks on Tuesday, saying, “Everything that I did was ethical, aboveboard, legal and transparent.”

Democrats accused Mr. Price of a potential conflict of interest at a hearing of the Senate Finance Committee, saying he held more than $100,000 in stock in companies that could have benefited from legislation he promoted. Mr. Price, a Georgia Republican, denied any wrongdoing.

He also avoided being pinned down on the future of the Affordable Care Act, Medicare and Medicaid, programs that insure more than 100 million people.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder